A federal judge ordered Guardant Health to pay over $245 million to TwinStrand Biosciences and the University of Washington. This judgment follows a jury verdict for infringing patented DNA sequencing technology. Guardan…
A federal judge ordered Guardant Health to pay over $245 million to TwinStrand Biosciences and the University of Washington. This judgment follows a jury verdict for infringing patented DNA sequencing technology. Guardant Health will pay an upfront amount and an ongoing royalty until March 2033. The company announced it will appeal the final judgment and is confident in its position.
Source: The Times of India — Top Stories
🔑 Key Takeaways
- Wire dispatch directly ingested from Times of India.
- Published at Wed, 26 Aug 2026 02:16.
- Source URL: https://timesofindia.indiatimes.com/technology/tech-news/us-court-to-pharma-giant-guardant-health-you-willfully-infringed-patents-for-cancer-testing-asked-to-pay-245-million-to-university-of-washington/articleshow/133527562.cms